BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 19944582)

  • 1. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco harm reduction: how rational public policy could transform a pandemic.
    Sweanor D; Alcabes P; Drucker E
    Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco control policies and the concurrent use of smokeless tobacco and cigarettes among men, 1992-2002.
    Mumford EA; Levy DT; Gitchell JG; Blackman KO
    Nicotine Tob Res; 2005 Dec; 7(6):891-900. PubMed ID: 16298724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Would alternate tobacco products use be better than smoking?
    Martinet Y; Bohadana A; Fagerström K
    Lung Cancer; 2006 Jul; 53(1):1-4. PubMed ID: 16690160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a comprehensive long term nicotine policy.
    Gray N; Henningfield JE; Benowitz NL; Connolly GN; Dresler C; Fagerstrom K; Jarvis MJ; Boyle P
    Tob Control; 2005 Jun; 14(3):161-5. PubMed ID: 15923465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
    Gartner CE; Hall WD; Chapman S; Freeman B
    PLoS Med; 2007 Jul; 4(7):e185. PubMed ID: 17608560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing smokeless tobacco products new tobacco-delivery systems.
    Hatsukami DK; Ebbert JO; Feuer RM; Stepanov I; Hecht SS
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S368-78. PubMed ID: 18021912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort.
    Galanti MR; Rosendahl I; Wickholm S
    Nicotine Tob Res; 2008 Feb; 10(2):315-23. PubMed ID: 18236296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction?
    Gartner CE; Jimenez-Soto EV; Borland R; O'Connor RJ; Hall WD
    Tob Control; 2010 Dec; 19(6):451-6. PubMed ID: 20671083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectories of smokeless tobacco use and of cigarette smoking in a cohort of Swedish adolescents: differences and implications.
    Rosendahl KI; Galanti MR; Gilljam H
    Nicotine Tob Res; 2008 Jun; 10(6):1021-7. PubMed ID: 18584465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.